Canaccord Genuity Downgrades Thoratec (THOR) to Hold

Go back to Canaccord Genuity Downgrades Thoratec (THOR) to Hold

Thoratec (THOR) PT Raised to $63.50 at Leerink Partners

August 5, 2015 12:17 PM EDT

Leerink Partners analyst Danielle Antalffy reiterated an Outperform rating and boosted her price target on Thoratec (NASDAQ: THOR) to $63.50 (from $50.00) following solid quarterly results, which they say reflects strong market growth. However, the pending STJ deal keeps a lid on the stock.

Antalffy commented, "In line with its... More

Thoratec (THOR) Tops Q2 EPS by 9c

August 4, 2015 4:23 PM EDT

Thoratec (NASDAQ: THOR) reported Q2 EPS of $0.37, $0.09 better than the analyst estimate of $0.28. Revenue for the quarter came in at $128.7 million versus the consensus estimate of $118 million.

For earnings history and earnings-related data on Thoratec (THOR) click here.

... More